Neonatal HBV vaccine reduces liver cancer risk
Tuesday, December 30, 2014 - 18:30
in Health & Medicine
Neonatal HBV vaccination reduces the risk of liver cancer and other liver diseases in young adults in China, according to a study. By collecting data on new cases of liver diseases over 30 years from a population-based tumor registry, the researchers estimated that the protective efficacy of vaccination was 84% for primary liver cancer (vaccination reduced the incidence of liver cancer by 84%), 70% for death from liver diseases, and 69% for the incidence of infant fulminant hepatitis.
